Skip to main content

Peer Review reports

From: Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: a retrospective study

Original Submission
16 Jan 2017 Submitted Original manuscript
11 Feb 2017 Reviewed Reviewer Report - Takashi Kobayashi
17 Feb 2017 Reviewed Reviewer Report - Mark Ball
18 Mar 2017 Author responded Author comments - Alison Johnson
Resubmission - Version 2
18 Mar 2017 Submitted Manuscript version 2
24 Apr 2017 Author responded Author comments - Alison Johnson
Resubmission - Version 3
24 Apr 2017 Submitted Manuscript version 3
Publishing
1 May 2017 Editorially accepted
22 May 2017 Article published 10.1186/s12885-017-3312-7

You can find further information about peer review here.

Back to article page